Additional neoadjuvant immunotherapy does not increase the risk of anastomotic leakage after esophagectomy for esophageal squamous cell carcinoma: a multicenter retrospective cohort study

PURPOSE: Neoadjuvant chemoimmunotherapy (nICT) is a novel and promising therapy model for locally advanced esophageal squamous cell carcinoma.The objective of this study aimed to assessed the impact of additional neoadjuvant immunotherapy on patients’ short-term outcomes, particularly the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Zhinuan, Xu, Jinxin, Chen, Zhen, Xu, Hui, Huang, Zhixin, Weng, Kai, Cai, Junlan, Ke, Sunkui, Chen, Shuchen, Xie, Jinbiao, Duan, Hongbing, Kang, Mingqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442078/
https://www.ncbi.nlm.nih.gov/pubmed/37318861
http://dx.doi.org/10.1097/JS9.0000000000000487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442078/
https://www.ncbi.nlm.nih.gov/pubmed/37318861
http://dx.doi.org/10.1097/JS9.0000000000000487

Ejemplares similares